<?xml version="1.0" encoding="UTF-8"?>
<p id="Par70">Gastrointestinal abnormalities were seen in 2%-10.1% of patients positive for SARS-CoV-2 [
 <xref ref-type="bibr" rid="CR60">60</xref>]. Symptoms including diarrhea and vomiting indicate that the virus can interact with cell populations in the gut. The ACE2 receptor is present in the gastrointestinal tract at significant amounts [
 <xref ref-type="bibr" rid="CR61">61</xref>]. Recently discovered, viral material was found to be present in infected individualsâ€™ fecal material [
 <xref ref-type="bibr" rid="CR62">62</xref>]. The phenomenon of gut-lung communication has been seen previously in other diseases, such as asthma [
 <xref ref-type="bibr" rid="CR63">63</xref>]. Further investigation is imperative to possibly mediate SARS-CoV-2 through probiotics or antibiotics [
 <xref ref-type="bibr" rid="CR60">60</xref>]. Although only a small percentage of patients experience gastrointestinal symptoms with SARS-CoV-2, this should be taken seriously as it may exacerbate pulmonary complications caused by the virus.
</p>
